DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 2.14% to $12.79 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.26% to 16,698.32 and Dow Jones Industrial Average falling 0.10% to 39,869.38.
The stock's fall snapped a three-day winning streak.
Inovio Pharmaceuticals Inc. closed $1.96 short of its 52-week high ($14.75), which the company reached on April 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.05% to $154.28, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.35% to $28.92.
Trading volume (365,972) remained 81,893 below its 50-day average volume of 447,865.
Data source: Dow Jones Market Data, FactSet. Data compiled May 16, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 16, 2024 17:31 ET (21:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments